AI Summary
Thinking
We reviewed 3 live results for cadaveric biospecimens and narrowed them down to the 3 options that look most worth comparing first.
The options are Customized Post-Mortem Tissue Procurement, Peripheral Blood Mononuclear Cells (PBMCs) and Access Rare Disease Samples from Patients Worldwide.
Source: NDRI
Description
NDRI provides customized post-mortem tissue procurement services for researchers, sourcing normal and diseased non-transplantable whole organs and tissue samples from cadaveric donors across a nationwide network of tissue banks. Recovered tissues have a post-mortem to preservation interval of 14 to 24 hours and can be preserved fresh, fixed, or frozen, with fresh or fixed media samples delivered within 36 to 72 hours post-mortem. Offerings support custom recovery protocols across body systems, including dedicated donor streams for HIV research.
Best for
Biomedical researchers, Scientific investigators, Custom human tissue acquisition for disease research and HIV/AIDS biomedical studies
Rate this product
Source: Discovery Life Sciences
Description
Discovery Life Sciences provides healthy and diseased Peripheral Blood Mononuclear Cells (PBMCs) isolated from over 1,100 patients for immunology, oncology, and advanced cell therapy research. Available from an extensive inventory or prospective collections, these viable cell biospecimens include longitudinal and matched sets with BMMCs, DTCs, FFPE, or tumoroids. Products are immunophenotyped by flow cytometry, characterized for cell count and viability via AO/PI staining, and cryopreserved in 1.0 mL aliquots containing approximately 5 million cells.
Best for
Immunology researchers, Oncology researchers, Immunology research and Oncology research
Rate this product
Source: Labtoo
Description
Labtoo provides a customized procurement service sourcing rare disease biological samples from patients worldwide for clinical and translational research. Sourcing covers diverse specimens including fresh, frozen, and FFPE tissues, whole blood, PBMC, plasma, serum, CSF, urine, and saliva from individuals with genetic and orphan conditions. Operating through retrospective biobank searches or tailored prospective clinical collections across Europe, North America, and international sites, Labtoo manages feasibility studies, ethical approvals, regulatory compliance, contracting, and material transfer.
Best for
Biotechnology Companies, Pharmaceutical Companies and Procuring rare and orphan disease biospecimens for drug discovery and biomarker research
Rate this product
| Compare | #1Customized Post-Mortem Tissue Procurement | #2Peripheral Blood Mononuclear Cells (PBMCs) | #3Access Rare Disease Samples from Patients Worldwide |
|---|---|---|---|
| Source | NDRI | Discovery Life Sciences | Labtoo |
| Description | NDRI provides customized post-mortem tissue procurement services for researchers, sourcing normal and diseased non-transplantable whole organs and tissue samples from cadaveric donors across a nationwide network of tissue banks. Recovered tissues have a post-mortem to preservation interval of 14 to 24 hours and can be preserved fresh, fixed, or frozen, with fresh or fixed media samples delivered within 36 to 72 hours post-mortem. Offerings support custom recovery protocols across body systems, including dedicated donor streams for HIV research. | Discovery Life Sciences provides healthy and diseased Peripheral Blood Mononuclear Cells (PBMCs) isolated from over 1,100 patients for immunology, oncology, and advanced cell therapy research. Available from an extensive inventory or prospective collections, these viable cell biospecimens include longitudinal and matched sets with BMMCs, DTCs, FFPE, or tumoroids. Products are immunophenotyped by flow cytometry, characterized for cell count and viability via AO/PI staining, and cryopreserved in 1.0 mL aliquots containing approximately 5 million cells. | Labtoo provides a customized procurement service sourcing rare disease biological samples from patients worldwide for clinical and translational research. Sourcing covers diverse specimens including fresh, frozen, and FFPE tissues, whole blood, PBMC, plasma, serum, CSF, urine, and saliva from individuals with genetic and orphan conditions. Operating through retrospective biobank searches or tailored prospective clinical collections across Europe, North America, and international sites, Labtoo manages feasibility studies, ethical approvals, regulatory compliance, contracting, and material transfer. |
| Best for | Biomedical researchers, Scientific investigators, Custom human tissue acquisition for disease research and HIV/AIDS biomedical studies | Immunology researchers, Oncology researchers, Immunology research and Oncology research | Biotechnology Companies, Pharmaceutical Companies and Procuring rare and orphan disease biospecimens for drug discovery and biomarker research |
| Action | NDRI | Discovery Life Sciences | Labtoo |
| Rate this product |
"Customized Post-Mortem Tissue Procurement from NDRI."
Note: TopFind AI compiles product and service information for general comparison purposes only.